These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 15687885)

  • 1. Helminths and the modulation of mucosal inflammation.
    Elliott DE; Summers RW; Weinstock JV
    Curr Opin Gastroenterol; 2005 Jan; 21(1):51-8. PubMed ID: 15687885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helminths and mucosal immune modulation.
    Weinstock JV
    Ann N Y Acad Sci; 2006 Aug; 1072():356-64. PubMed ID: 17057216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helminths as governors of immune-mediated inflammation.
    Elliott DE; Summers RW; Weinstock JV
    Int J Parasitol; 2007 Apr; 37(5):457-64. PubMed ID: 17313951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New mediators of immunity and inflammation in inflammatory bowel disease.
    Monteleone G; Fina D; Caruso R; Pallone F
    Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Helminths and inflammatory bowel diseases].
    Laclotte C; Oussalah A; Rey P; Bensenane M; Pluvinage N; Chevaux JB; Trouilloud I; Serre AA; Boucekkine T; Bigard MA; Peyrin-Biroulet L
    Gastroenterol Clin Biol; 2008 Dec; 32(12):1064-74. PubMed ID: 18619749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for helminths in the therapy of inflammatory bowel disease?
    Summers RW; Elliott DE; Weinstock JV
    Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):62-3. PubMed ID: 16265104
    [No Abstract]   [Full Text] [Related]  

  • 7. Where are we on worms?
    Elliott DE; Weinstock JV
    Curr Opin Gastroenterol; 2012 Nov; 28(6):551-6. PubMed ID: 23079675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy. Can worms tame the immune system?
    Wickelgren I
    Science; 2004 Jul; 305(5681):170-1. PubMed ID: 15247451
    [No Abstract]   [Full Text] [Related]  

  • 9. Trichuris suis ova: testing a helminth-based therapy as an extension of the hygiene hypothesis.
    Jouvin MH; Kinet JP
    J Allergy Clin Immunol; 2012 Jul; 130(1):3-10; quiz 11-2. PubMed ID: 22742834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichuris suis excretory secretory products (ESP) elicit interleukin-6 (IL-6) and IL-10 secretion from intestinal epithelial cells (IPEC-1).
    Parthasarathy G; Mansfield LS
    Vet Parasitol; 2005 Aug; 131(3-4):317-24. PubMed ID: 15978725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathogenesis of inflammatory bowel disease: current concepts.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
    Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
    J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can helminths or helminth-derived products be used in humans to prevent or treat allergic diseases?
    Erb KJ
    Trends Immunol; 2009 Feb; 30(2):75-82. PubMed ID: 19138565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic and molecular mechanisms in inflammatory bowel disease.
    Ince MN; Elliott DE
    Surg Clin North Am; 2007 Jun; 87(3):681-96. PubMed ID: 17560420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity in inflammatory bowel disease: state of the art.
    Hisamatsu T; Ogata H; Hibi T
    Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency.
    Mannon PJ; Fuss IJ; Dill S; Friend J; Groden C; Hornung R; Yang Z; Yi C; Quezado M; Brown M; Strober W
    Gastroenterology; 2006 Sep; 131(3):748-56. PubMed ID: 16952544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB in inflammatory bowel disease.
    Atreya I; Atreya R; Neurath MF
    J Intern Med; 2008 Jun; 263(6):591-6. PubMed ID: 18479258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of action of probiotics.
    Boirivant M; Strober W
    Curr Opin Gastroenterol; 2007 Nov; 23(6):679-92. PubMed ID: 17906447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.
    Mankertz J; Schulzke JD
    Curr Opin Gastroenterol; 2007 Jul; 23(4):379-83. PubMed ID: 17545772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate antimicrobial immunity in inflammatory bowel diseases.
    Beisner J; Stange EF; Wehkamp J
    Expert Rev Clin Immunol; 2010 Sep; 6(5):809-18. PubMed ID: 20828289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.